Published :
Tables : 63
Figures : 43
Category : Healthcare
No. of Pages : 223
Report Code : HC-U3309
Lacrimal Duct Stent Tube Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027. Rising patient population, growing demand for minimally invasive treatments are some of the factors responsible for the growth of the market. Dacryostenosis or nasolacrimal duct obstruction is the most prevalent lacrimal system disorder. As per the article ‘Nasolacrimal Duct Obstruction’ published in 2020, over 15% of infant patients possessing with some symptoms. The rate of spontaneous NLDO resolution with over 65% of affected children getting symptom-free within 3 months and over 85% recovering within a year. On the other hand, new-born babies at a high risk for this condition which include ectrodactyly-ectodermal dysplasia-cleft lip syndrome, trisomy 21, coloboma, heart anomaly, choanal atresia and retardation syndrome, branchiooculofacial syndrome, Goldenhar syndrome. Therefore, the rising incidence of such conditions shall propel the lacrimal duct stent tube market growth. Lacrimal intubation has been a very prevalent surgery for congenital NLDO over the past few years. This procedure does not respond to failed probing or conservative medical treatments. Furthermore, there are other health conditions related to lacrimal duct obstruction like for instance, dacryocystitis is an inflammation caused in the nasolacrimal sac is generally followed by nasolacrimal duct blockage. Owing to the high incidence of such conditions shall boost the proliferation of the market. Market Segmentation: By Product Type • Monocanalicular Lacrimal Duct Stent Tube • Bicanalicular Lacrimal Duct Stent Tube By End User • Hospitals • Ophthalmic Clinics • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is diversified into product type, end user and region. The product type segment is classified into monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube. The bicanalicular lacrimal duct stent tube is predicted to account the largest lacrimal duct stent tube market share owing to tits high rate of success, especially with child patients. Bicanalicular lacrimal tubes consists of two probes with a stent that intervenes. One probe passes through the lower punctum while the other through upper punctum. The silicone tube free ends are tied in the nose and the probes are removed. The end user segment is categorised into hospitals, ophthalmic clinics and others. The hospitals segment is anticipated to dominate the market during the forecast period owing to advancements in hospital infrastructure and rise in the number of hospitals in the developing nations. Regional Analysis: The North America region is predicted to lead the market owing to improved surgical service regulations and rising awareness amongst the general population regarding the approach for these procedures. Furthermore, key market players have strategized acquisitions with major hospitals and clinics for expanding their business operations in the region. Competitive Landscape: The major market players associated are Aurolab, Bess Medizintechnik GmbH, FCI Ophthalmics, Gunther Weiss Scientific Glass, Kaneka Pharma America LLC. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global lacrimal duct stent tube market by product type, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rising patient population, growing demand for minimally invasive treatments are some of the factors responsible for the growth of the market. Dacryostenosis or nasolacrimal duct obstruction is the most prevalent lacrimal system disorder. As per the article ‘Nasolacrimal Duct Obstruction’ published in 2020, over 15% of infant patients possessing with some symptoms. The rate of spontaneous NLDO resolution with over 65% of affected children getting symptom-free within 3 months and over 85% recovering within a year. On the other hand, new-born babies at a high risk for this condition which include ectrodactyly-ectodermal dysplasia-cleft lip syndrome, trisomy 21, coloboma, heart anomaly, choanal atresia and retardation syndrome, branchiooculofacial syndrome, Goldenhar syndrome. Therefore, the rising incidence of such conditions shall propel the lacrimal duct stent tube market growth. Lacrimal intubation has been a very prevalent surgery for congenital NLDO over the past few years. This procedure does not respond to failed probing or conservative medical treatments. Furthermore, there are other health conditions related to lacrimal duct obstruction like for instance, dacryocystitis is an inflammation caused in the nasolacrimal sac is generally followed by nasolacrimal duct blockage. Owing to the high incidence of such conditions shall boost the proliferation of the market.
Market Segmentation:
By Product Type • Monocanalicular Lacrimal Duct Stent Tube • Bicanalicular Lacrimal Duct Stent Tube By End User • Hospitals • Ophthalmic Clinics • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is diversified into product type, end user and region. The product type segment is classified into monocanalicular lacrimal duct stent tube, bicanalicular lacrimal duct stent tube. The bicanalicular lacrimal duct stent tube is predicted to account the largest lacrimal duct stent tube market share owing to tits high rate of success, especially with child patients. Bicanalicular lacrimal tubes consists of two probes with a stent that intervenes. One probe passes through the lower punctum while the other through upper punctum. The silicone tube free ends are tied in the nose and the probes are removed. The end user segment is categorised into hospitals, ophthalmic clinics and others. The hospitals segment is anticipated to dominate the market during the forecast period owing to advancements in hospital infrastructure and rise in the number of hospitals in the developing nations.
Regional Analysis:
The North America region is predicted to lead the market owing to improved surgical service regulations and rising awareness amongst the general population regarding the approach for these procedures. Furthermore, key market players have strategized acquisitions with major hospitals and clinics for expanding their business operations in the region.
Competitive Landscape:
The major market players associated are Aurolab, Bess Medizintechnik GmbH, FCI Ophthalmics, Gunther Weiss Scientific Glass, Kaneka Pharma America LLC.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global lacrimal duct stent tube market by product type, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Lacrimal Duct Stent Tube Market, By Product Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Monocanalicular Lacrimal Duct Stent Tube 7.2 Bicanalicular Lacrimal Duct Stent Tube 8. Lacrimal Duct Stent Tube Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Hospitals 8.2 Ophthalmic Clinics 8.3 Others 9. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 9.2.1. U.S. 9.2.2. Canada 9.2.3. Mexico 9.2.4 Rest of North America 9.3 Market Size (USD Mn) Forecast for North America 2020-2027 10. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Uruguay 10.3.3 Argentina 10.3.4. Rest of Latin America 10.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5 Switzerland 11.2.6. Spain 11.2.7. Russia 11.2.8. Poland 11.2.9. Rest of Western Europe 11.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 Japan 12.2.2 China 12.2.3 Singapore 12.2.4 Korea 12.2.5 India 12.2.6 Australia and New Zealand 12.2.7 ASEAN 12.2.8 Rest of Asia Pacific 12.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 UAE 13.2.2 South Africa 13.2.3 Egypt 13.2.4 Saudi Arabia 13.2.5 Rest of MEA 13.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 Aurolab 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Bess Medizintechnik GmbH 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 FCI Ophthalmics 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 Gunther Weiss Scientific Glass 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Kaneka Pharma America LLC 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 15. Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. Competitive Intelligence and Competitive Matrix 16.1 Competitive Intelligence 16.2 Competitive Matrix 17. Major Deals and Strategic Alliances Analysis 17.1 Joint ventures 17.2 Mergers and acquisitions 17.3 Licensing and partnerships 17.4 Technology Collaborations 17.5 Strategic Divestments 17.6 Market Entry Strategies 18. Relevant Case Studies and Latest News Updates 19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics